LINC02122

Across TCGA pan-cancer cohorts, LINC02122 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated LINC02122 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher LINC02122 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02122 expression acts as an unfavorable survival marker, although some lineages such as HNSC and CESC show a favorable association.

UCS, LGG, and UCEC are the cancer types where LINC02122 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	DFS	Tertile	IV	0.132	0.718	.002	36	view →
LGG	OS	Tertile	All	0.745	0.901	.003	33	view →
UCEC	DFS	Tertile	All	0.333	0.722	.008	22	view →
DLBC	DFS	Tertile	III,IV	0.137	0.790	<.001	18	view →
KIRC	DFS	Tertile	IV	0.249	0.546	.023	18	view →
READ	DFS	Tertile	IV	0.362	0.687	.001	18	view →
LAML	DFS	Tertile	All	0.111	0.578	.001	18	view →
HNSC	DFS	Tertile	III,IV	0.482	0.306	.043	15	view →
BRCA	OS	Tertile	III,IV	0.741	0.857	.027	12	view →
KICH	OS	Quartile	All	0.870	0.992	.015	11	view →
SKCM	DFS	Tertile	All	0.313	0.644	.025	9	view →
THCA	DFS	Tertile	All	0.805	0.946	.011	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

LINC02122–UCS (DFS)

Open the UCS breakdown →